PROTHROMBIN (FACTOR II) GENE MUTATION

Prothrombin (Factor II) Gene Mutation testing is a specialized molecular genetic test used to identify inherited mutations in the prothrombin (F2) gene, most commonly the G20210A mutation. This genetic variation is associated with increased production of prothrombin, a clotting protein that plays a key role in blood coagulation. Individuals carrying this mutation may have an increased risk of developing abnormal blood clots, also known as thrombosis.

This test is commonly recommended for individuals with unexplained deep vein thrombosis (DVT), pulmonary embolism, recurrent blood clots, pregnancy complications related to thrombosis, or a family history of inherited clotting disorders. Early identification of a Prothrombin gene mutation helps physicians assess clotting risk and guide preventive healthcare decisions.

Benefits of the Test

• Detects inherited Prothrombin (Factor II) gene mutations.
• Helps identify genetic risk factors for thrombosis.
• Supports evaluation of inherited thrombophilia.
• Assists in blood clot risk assessment.
• Supports personalized treatment and prevention strategies.
• Provides valuable information for family screening.
• Helps guide pregnancy-related risk management.
• Offers accurate molecular genetic diagnosis.

Why Doctors Recommend This Test

Doctors recommend Prothrombin Gene Mutation testing for patients with unexplained venous thrombosis, recurrent blood clots, thrombosis at a young age, family history of clotting disorders, pregnancy-related complications, or before initiating certain treatments that may affect clotting risk. The test helps identify inherited susceptibility to abnormal clot formation.

Preparation Before Test

• No fasting is generally required.
• A blood sample is collected for genetic analysis.
• Provide details of previous clotting events if applicable.
• Inform your doctor about anticoagulant medications.
• Share family history of thrombosis or clotting disorders.
• Follow all sample collection instructions provided by the laboratory.

Normal Reporting Time

Most Prothrombin (Factor II) Gene Mutation reports at Focus Diagnostics are initiated within 2–3 hours of sample receipt for accessioning, DNA extraction, and molecular workflow preparation. Final genetic analysis, mutation detection, interpretation, quality review, and report generation are generally completed within several working days depending on laboratory protocols and quality assurance procedures.

Who Should Take This Test?

This test may be recommended for:

• Individuals with deep vein thrombosis (DVT).
• Patients with pulmonary embolism.
• People with recurrent blood clotting episodes.
• Individuals with a family history of thrombophilia.
• Women with recurrent pregnancy loss related to clotting disorders.
• Patients with unexplained thrombosis at a young age.
• Individuals undergoing thrombophilia evaluation.
• People requiring genetic clotting risk assessment.

Detailed Information

The prothrombin gene, also known as Factor II (F2), provides instructions for producing prothrombin, a protein that plays a central role in the blood clotting process. The most common inherited mutation affecting this gene is the G20210A variant, which can result in elevated prothrombin levels and an increased tendency for blood clot formation.

Individuals carrying the Prothrombin G20210A mutation may have a higher risk of developing venous thromboembolism, including deep vein thrombosis and pulmonary embolism. The risk may be further increased when combined with other genetic or acquired risk factors such as surgery, prolonged immobility, pregnancy, hormonal therapy, obesity, or smoking.

Genetic testing for Prothrombin mutations is an important component of thrombophilia evaluation. It helps physicians identify inherited clotting predispositions and determine whether additional preventive measures, monitoring, or treatment strategies may be appropriate.

The test uses advanced molecular diagnostic techniques to detect specific genetic variants within the F2 gene. Results are interpreted together with personal medical history, family history, laboratory findings, and other thrombophilia investigations such as Factor V Leiden testing.

Because genetic variations remain constant throughout life, testing generally needs to be performed only once. Positive findings may provide valuable information not only for the patient but also for family members who may share inherited risk factors.

Results should always be interpreted in conjunction with clinical assessment and physician recommendations. Additional coagulation studies or genetic tests may be advised depending on the individual's medical history and risk profile.

At Focus Diagnostics, Prothrombin (Factor II) Gene Mutation testing is performed using advanced molecular diagnostic technologies, validated genetic analysis methods, and stringent quality assurance standards to provide accurate, reliable, and clinically meaningful thrombophilia risk assessment results.